- Home
- LARK vs ALEC Comparison
LARK vs ALEC Comparison
Compare LARK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LARK
- ALEC
- Stock Information
- Founded
- LARK 1885
- ALEC 2013
- Country
- LARK United States
- ALEC United States
- Employees
- LARK N/A
- ALEC N/A
- Industry
- LARK Major Banks
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LARK Finance
- ALEC Health Care
- Exchange
- LARK Nasdaq
- ALEC Nasdaq
- Market Cap
- LARK 135.9M
- ALEC 162.6M
- IPO Year
- LARK N/A
- ALEC 2019
- Fundamental
- Price
- LARK $27.21
- ALEC $1.23
- Analyst Decision
- LARK
- ALEC Buy
- Analyst Count
- LARK 0
- ALEC 7
- Target Price
- LARK N/A
- ALEC $4.10
- AVG Volume (30 Days)
- LARK 24.6K
- ALEC 565.4K
- Earning Date
- LARK 04-30-2025
- ALEC 05-07-2025
- Dividend Yield
- LARK 3.08%
- ALEC N/A
- EPS Growth
- LARK 6.33
- ALEC N/A
- EPS
- LARK 2.26
- ALEC N/A
- Revenue
- LARK $58,168,000.00
- ALEC $100,558,000.00
- Revenue This Year
- LARK N/A
- ALEC N/A
- Revenue Next Year
- LARK N/A
- ALEC $40.79
- P/E Ratio
- LARK $12.00
- ALEC N/A
- Revenue Growth
- LARK 3.55
- ALEC 3.60
- 52 Week Low
- LARK $17.05
- ALEC $1.20
- 52 Week High
- LARK $28.55
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- LARK 65.83
- ALEC 34.56
- Support Level
- LARK $26.75
- ALEC $1.26
- Resistance Level
- LARK $27.50
- ALEC $1.36
- Average True Range (ATR)
- LARK 1.04
- ALEC 0.09
- MACD
- LARK 0.19
- ALEC 0.00
- Stochastic Oscillator
- LARK 69.83
- ALEC 7.89
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.